165 Fleet Street,
London EC4A 2DY
United Kingdom
+44 (0) 20 7242 5905
www.memerycrystal.com
Memery Crystal LLP is an independent law firm focused on providing legal advisory services to clients from individual entrepreneurs and owner-managed businesses, to City institutions and multi-national corporations. The Firm's practice areas include corporate, mergers and acquisitions, real estate, tax, intellectual property, employment, equity capital markets, financial services and regulation, and dispute resolution. The Firm's clients include companies from the environmental, financial services, information technology, leisure, media, real estate, retail, software, and technology hardware sectors. Memery Crystal was founded in 1978 and is based in London.
| Year | ≤ '19 | '20 | '21 | '22 | '23 | '24 | T |
|---|---|---|---|---|---|---|---|
| Buyside (0.2/yr) | - | - | 1 | - | - | - | 1 |
| Sellside (0.2/yr) | 1 | - | - | 1 | - | - | 2 |
| 3 | |||||||
| Target Company | Date | Value | Type |
|---|---|---|---|
| Sign-up to View | 2022-08-11 | - | Chemicals |
| Sign-up to View | 2021-03-09 | 343M USD | Consumer Products |
| Sign-up to View | 2014-10-23 | 109M USD | Construction |
| View All >> | |||
| Sector | # | Value | |
|---|---|---|---|
| Consumer Products | Sign-up to View | ||
| Construction | Sign-up to View | ||
| Chemicals | Sign-up to View | ||
| Total | Sign-up to View | ||
| State/Country | # | Value | |
|---|---|---|---|
| United Kingdom | Sign-up to View | ||
| Monaco | Sign-up to View | ||
| Domestic | Sign-up to View | ||
| Cross-border | Sign-up to View | ||
| Total | Sign-up to View | ||
| Type | # | Value | |
|---|---|---|---|
| Add-on Acquisition | Sign-up to View | ||
| Buyout (LBO, MBO, MBI) | Sign-up to View | ||
| Total | Sign-up to View | ||
| Corporate (3) | Deals |
|---|---|
|
Sign-up to View |
1 |
|
Sign-up to View |
1 |
|
Sign-up to View |
1 |
| Value | # | TOTAL |
|---|---|---|
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| TOTAL | Sign-up to View | |
| Largest |
EMMAC Life Sciences Ltd. $343M (2021-03-09) |
|
